Apis Capital Advisors, LLC Liquidia Corp Transaction History

Apis Capital Advisors, LLC

  • $108 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$3.73 - $8.39 $149,200 - $335,600
40,000 Added 80.0%
90,000 $490,000
Q2 2022

Aug 12, 2022
SELL
$3.37 - $7.55 $67,400 - $151,000
-20,000 Reduced 28.57%
50,000 $218,000
Q1 2022

May 13, 2022
BUY
$5.14 - $7.38 $359,800 - $516,600
70,000 New
70,000 $503,000

Others Institutions Holding LQDA

# of Institutions
162
Shares Held
36M
Call Options Held
1.79M
Put Options Held
380K
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Apis Capital Advisors, LLC Portfolio

Follow Apis Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apis Capital Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email